| Total | Group 1 | Group 2 | Group 3 |
---|---|---|---|---|
Market size of the originator drug | 1.56 (0.63) | 1.52 (0.66) | 1.82 (0.39) | 1.29 (0.70) |
Expectations for succeeding in litigation | 1.18 (0.90) | 1.43 (0.58) | 1.09 (1.00) | 0.57 (1.18) |
Expectations for manufacturing a generic drug | 1.03 (0.80) | 0.90 (0.92) | 1.27 (0.62) | 1.00 (0.53) |
Sales force of a manufacturer | 0.87 (0.82) | 0.86 (0.77) | 1.09 (0.90) | 0.57 (0.73) |
Market power of a manufacture | 0.85 (0.74) | 1.00 (0.62) | 0.45 (0.89) | 1.00 (0.53) |
Product portfolios of a manufacturer | 0.79 (0.76) | 1.00 (0.69) | 0.73 (0.86) | 0.29 (0.45) |
Expectations for collaboration with other manufacturers | 0.69 (0.99) | 0.62 (0.90) | 1.18 (0.94) | 0.14 (0.99) |
Expected cost of a court litigation | -0.13 (0.88) | -0.29 (0.76) | 0.00 (1.04) | 0.14 (0.83) |